financetom
Business
financetom
/
Business
/
Oil Falls Off a Five-Week High as Rising U.S. Inventories Counter Threatened Russian Sanctions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Falls Off a Five-Week High as Rising U.S. Inventories Counter Threatened Russian Sanctions
Jul 31, 2025 6:22 AM

08:46 AM EDT, 07/31/2025 (MT Newswires) -- Oil traded lower early on Thursday, falling off a five-week high after an unexpected rise in U.S oil inventories and despite fresh sanction threats on Russian supply from the Trump Administration.

West Texas Intermediate crude for September delivery was last seen down US$0.32 to US$69.68 per barrel, falling off the highest since June 20, while September Brent oil was down US$0.40 to US$72.84.

The drop comes after the Energy Information Administration on Wednesday reported U.S. commercial oil inventories rose by 7.7-million barrels last week, while the consensus estimate among analysts polled by Reuters expected a drop of 1.3-million barrels.

"Commercial crude inventories soared +7.7mmbbls last week, with stocks now tracking -1% y/y and -6% below the 5y average. The build was supported by crude exports plunging -1,157mbpd coupled with crude imports climbing +159mbpd," Tudor, Pickering, Holt analyst Jenny Ryu noted.

Threats from U.S President to impose secondary sanctions on India for buying Russian oil as he imposed a 25% tariff on goods from the country are offering some support to the commodity even as the market is over-supplied.

With Western hemisphere production also increasing, OPEC+ is returning 2.2-million barrels per day of production cuts to market in monthly tranches that began in May, with the full return expected to be complete in September.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alvotech, Teva's Stelara Biosimilar Gets FDA Approval for New IV Presentation
Alvotech, Teva's Stelara Biosimilar Gets FDA Approval for New IV Presentation
Oct 22, 2024
07:53 AM EDT, 10/22/2024 (MT Newswires) -- Alvotech ( ALVO ) and Teva Pharmaceuticals (TEVA) said Tuesday the US Food and Drug Administration has approved a new intravenous formulation of Selarsdi, a biosimilar to Stelara, in a 130 mg/26 ml single-dose vial. Approval of Selarsdi in new presentation expands the label to cover the treatment of adults with Crohn's disease...
Foremost Clean Energy Announces
Foremost Clean Energy Announces "Positive" Preliminary Results From Hatchet Lake Uranium Property
Oct 22, 2024
07:47 AM EDT, 10/22/2024 (MT Newswires) -- Foremost Clean Energy ( FMST ) , an uranium and lithium exploration company, announced Tuesday positive preliminary results from an 889 metre, four-hole diamond drill program that was recently completed at the Hatchet Lake property in northern Saskatchewan. Preliminary drill highlights include elevated radioactivity of up to 360 counts per second (cps) from...
German govt not planning talks with UniCredit management, reports Handelsblatt
German govt not planning talks with UniCredit management, reports Handelsblatt
Oct 22, 2024
BERLIN, Oct 22 (Reuters) - The German government is not planning any talks with the management of Italy's UniCredit on the potential takeover of Commerzbank, the Handelsblatt newspaper reported on Tuesday, citing a parliamentary response. The newspaper cited a finance ministry official as writing: Talks about a potential merger of two private companies are the responsibility of the respective bodies...
Invesco Q3 Earnings Rise, Net Revenue Unchanged; Maintains Quarterly Dividend
Invesco Q3 Earnings Rise, Net Revenue Unchanged; Maintains Quarterly Dividend
Oct 22, 2024
07:49 AM EDT, 10/22/2024 (MT Newswires) -- Invesco ( IVZ ) reported Q3 adjusted earnings Tuesday of $0.44 per diluted share, up from $0.35 a year earlier. Analysts polled by Capital IQ expected $0.43. Net revenue for the quarter ended Sept.30 was $1.10 billion, roughly unchanged compared with a year earlier. Analysts surveyed by Capital IQ expected $1.11 billion. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved